Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03610022
Title Relationship Between Pharmacokinetics and Safety of Vismodegib - OPTIVISMO-1 (OPTIVISMO-1)
Recruitment Completed
Gender both
Phase FDA approved
Variant Requirements No
Sponsors University Hospital, Bordeaux
Indications

epidermal appendage tumor

basal cell carcinoma

Therapies

Vismodegib

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.